SMITH ANDREW ALASDAIR (Chief Operating Officer) received a stock award from MEDICUS PHARMA LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/8/2026ACC: 0000950142-26-002522
Officer· Chief Operating Officer
Since Jun 2025
+860.29K
Net shares
Net buyer
$125.4K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
860.29K acquired
Non-Derivative Transactions1
Common Shares, no par value
Direct
Shares
+735.29K
Price / share
$0.17
Trade value
$125.37K
% of position
448350.0%
9/4/2026
164.00→735.46K
Total
Net shares
+735.29K
Net value
$125.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par value Direct | 9/4/2026 | A · Award | +735.29K | $0.17 | $125.37K | 448350.0% | 164.00 | 735.46K |
| Total | +735.29K | $125.37K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Shares
125K shares
Shares
+125K
Strike price
0.1705
Held after
125K
Exercisable
—
9/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Shares125K shares | 9/4/2026 | A · Award | +125K | 0.1705 | — | 125K |